Biotech Values

[EyeamBill]

Sandoz is only getting the 30,40mg business as far as I know in the retail setting.

While "only" is a strong word I do agree with the gist of your point. At least until February 28th, after which time Sandoz m-Enox will be a player in the higher and just as importantly twice-as-frequent dosing.

What's more, these things tend to snowball and I wouldn't be surprised if other GPOs are picked off one-by-one. Maybe Teva should have stopped poking the bear with a stick, huh?

Sorry I didn't see your post regarding the HPG news first. I hadn't read it until after I had posted. I would have probably saved everybody my lengthy preamble had I known it was reported previously.

Bill